How Do I Reach My Support Team? | Calibrate

At a glance
- Primary contact method / In-app messaging through the Calibrate mobile app
- Typical coach response time / Within 1 business day
- Medical question routing / Escalated to prescribing physician via app
- Urgent account issues / Email or phone support available
- Program structure / 1-year metabolic health program with ongoing coaching
- GLP-1 drugs used / Semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda)
- Clinical visit cadence / Regular video check-ins with board-certified physicians
- Evidence base / STEP-1 (N=1,961) 14.9% mean weight loss at 68 weeks with semaglutide 2.4 mg
The Fastest Way to Contact Calibrate Support
The fastest and most reliable way to contact your Calibrate support team is through in-app messaging inside the Calibrate mobile app. Open the app, tap the messaging icon, and type your question directly to your assigned health coach. Responses arrive within one business day for non-urgent matters, and the same thread escalates to a physician when a clinical decision is needed.
Using In-App Messaging
Once you are logged in, the messaging tab sits at the bottom of the home screen. Your conversation history stays in one thread, which means your coach sees everything you have written before. That context matters: a coach who knows your dose history, your side-effect log, and your last weigh-in can give meaningfully better guidance than one reading your case cold.
Attach photos or screenshots directly in the chat if you need to show a medication label, a pharmacy error notice, or a symptom you are tracking. The app accepts standard image formats.
When the App Is Not Available
If the app is down or you cannot log in, Calibrate's member support email (listed in your original welcome email and in the app's Help section) is the next best option. Response times via email are longer than in-app messaging, so save email for account-level issues such as billing disputes or login recovery rather than clinical questions.
Phone support is available for urgent account matters. The number appears in the Help section of the app and in your onboarding documentation. Phone lines are staffed during business hours on weekdays.
What Counts as Urgent vs. Non-Urgent
Use in-app messaging for dose questions, scheduling conflicts, side-effect check-ins, and behavioral coaching topics. Call or go to an emergency room immediately for chest pain, severe allergic reaction, signs of pancreatitis (persistent upper-abdominal pain radiating to the back), or vision changes. GLP-1 medications carry an FDA-required warning for thyroid C-cell tumors in rodents, and while the human risk is not established, any new neck mass warrants a same-day physician call rather than an app message [1].
Why Consistent Support Access Matters for GLP-1 Outcomes
Access to a support team is not a customer-service nicety in a GLP-1 program. It is a clinical variable. The STEP-1 trial (N=1,961) showed that semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks versus 2.4% on placebo, but that result was achieved inside a structured program with regular lifestyle counseling visits [2]. Stripping away that support layer leaves the pharmacology working alone, which produces measurably worse adherence.
Behavioral Coaching and Medication Adherence
A 2021 analysis published in Obesity found that patients who received structured behavioral support alongside pharmacotherapy were significantly more likely to remain on therapy at 12 months than those receiving pharmacotherapy alone [3]. Calibrate's model pairs each member with a health coach trained in motivational interviewing, a technique with its own evidence base in weight management [4].
Dose escalation schedules for semaglutide run over 16 to 20 weeks. Missing a check-in during that window can mean staying on a sub-therapeutic dose longer than necessary, or moving up too fast and triggering nausea that drives discontinuation. Your coach tracks that schedule and flags it when a video visit with the prescribing physician is due.
Physician Oversight in a Telehealth Model
Calibrate operates under a physician-led model. The prescribing clinicians are board-certified in obesity medicine or an adjacent specialty. The American Board of Obesity Medicine (ABOM) currently certifies physicians in this specialty, and the Obesity Medicine Association publishes clinical practice guidelines that inform how programs like Calibrate structure their titration protocols [5].
The FDA approved semaglutide 2.4 mg (Wegovy) for chronic weight management in June 2021 for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity [1]. Liraglutide 3.0 mg (Saxenda) received approval for the same indication in 2014. Both require a valid prescription from a licensed physician, which is why Calibrate's support structure routes clinical questions to that prescribing layer rather than resolving them at the coach level.
What Your Support Team Can and Cannot Do
Coaches can adjust your behavioral plan, help you troubleshoot mild side effects (nausea, constipation, injection-site reactions), and schedule physician video visits. They cannot change your prescription dose, authorize refills, or diagnose new conditions. That boundary is not arbitrary: it aligns with state scope-of-practice laws and with CMS telehealth prescribing regulations that govern how GLP-1 medications are dispensed through telehealth platforms [6].
Understanding Calibrate's Care Team Structure
Calibrate's support team has three distinct layers. Knowing which layer handles which problem saves you time.
Layer 1: Health Coaches
Health coaches are your primary day-to-day contact. They hold sessions focused on the four pillars Calibrate emphasizes: food, sleep, exercise, and emotional health. Each pillar has a measurable behavioral target. Coaches meet with members via video on a schedule set during onboarding, typically monthly in the early dose-escalation phase and quarterly once you reach a maintenance dose.
Sleep quality is one pillar coaches address actively. Poor sleep elevates ghrelin and suppresses leptin, increasing hunger and reducing the subjective benefit of GLP-1 therapy [7]. A 2022 paper in the Journal of Clinical Endocrinology and Metabolism found that sleep restriction of two weeks attenuated GLP-1 secretion in healthy adults, which suggests that sleep coaching is not ancillary to the pharmacology but is part of the same mechanism [8].
Layer 2: Prescribing Physicians
Prescribing physicians handle dose changes, new symptom evaluation, lab review, and any clinical decision that falls outside a coach's scope. You reach them through the same in-app messaging thread: your coach escalates the message, or you can flag it as a medical question directly in the app. Video visits with the physician are scheduled through the app's booking calendar.
Physicians review labs before initiating therapy and at regular intervals. Standard labs for a GLP-1 program include a comprehensive metabolic panel, HbA1c, fasting lipids, TSH, and a pregnancy test for women of childbearing age. The American Association of Clinical Endocrinology (AACE) 2023 obesity guidelines recommend at minimum a fasting glucose and lipid panel before starting any GLP-1 agonist [9].
Layer 3: Member Support Specialists
Member support specialists handle everything that is not clinical: billing, insurance questions, prescription logistics, pharmacy transfers, and app technical issues. They do not have access to your medical record in the same way coaches and physicians do. Reach them via the Help section of the app or through the member support email in your welcome documentation.
Navigating Common Support Scenarios
Your Medication Did Not Arrive
Contact member support (not your coach) first. Prescription logistics sit with the pharmacy and the support specialist team. Have your tracking number and pharmacy name ready. If a dose is going to be delayed more than a few days, your physician may advise whether to hold, use a prior dose pen, or bridge with a different strategy. Do not make that call independently: skipping multiple injections or doubling a dose can restart side-effect cycles.
You Are Experiencing Side Effects
Nausea affects roughly 44% of patients on semaglutide 2.4 mg during dose escalation, per the STEP-1 trial data [2]. Vomiting, diarrhea, and constipation are also common. Message your coach through the app and describe the severity on a 1-to-10 scale, when it started relative to your injection, and whether it is improving or worsening. The coach will either provide behavioral strategies (smaller meals, slower eating, ginger tea for nausea) or escalate to the physician for a dose-hold decision.
Pancreatitis is rare but serious. The FDA label for semaglutide lists pancreatitis as a risk requiring discontinuation if confirmed [1]. Persistent, severe upper abdominal pain that radiates to the back is not a message-your-coach situation. Go to an emergency department.
You Want to Pause or Stop the Program
This is a common conversation coaches have. Weight regain after GLP-1 discontinuation is well-documented: the STEP-4 withdrawal trial (N=803) showed that participants who switched from semaglutide to placebo at week 20 regained two-thirds of their prior weight loss by week 68 [10]. Your coach and physician can discuss whether a planned pause, a dose reduction to a maintenance level, or a transition strategy fits your situation better than stopping cold.
You Have a Billing or Insurance Question
Calibrate's GLP-1 medications are not universally covered by insurance. The support specialist team can provide a letter of medical necessity for your insurer, document your clinical eligibility, and advise on manufacturer savings programs. Novo Nordisk operates a savings program for Wegovy that may reduce out-of-pocket cost for eligible commercially insured patients. Reach the specialist team through the Help section of the app.
Getting More From Your Coaching Sessions
Prepare Before Each Video Visit
Bring three specific data points to every coaching session: your current weight trend over the past two weeks (not just today's number), your most new eating or sleep pattern from that period, and one question you want answered by the physician at your next clinical visit. Coaches can carry questions forward, but they need them explicitly stated.
Use the App's Logging Features
Calibrate's app includes food logging, weight tracking, and a sleep log. Data you enter there is visible to your coach before the session. A study in JAMA Internal Medicine (N=105) found that patients who logged food daily lost significantly more weight at 6 months than infrequent loggers [11]. More frequent logging also gives the clinical team better signal for adjusting behavioral recommendations between visits.
Be Specific About Side Effects
Vague reports ("I feel bad") produce vague responses. "I have had grade 2 nausea for four hours after each injection for the past three weeks, and I have lost 2 pounds but missed two meals this week because of it" gives a coach and physician enough to act on. Specific reporting is the mechanism through which your support team can actually help you.
The Clinical Case for Structured Telehealth Support
Telehealth-delivered obesity care has been tested in controlled settings. A 2020 randomized trial published in Obesity (N=389) compared telehealth-based behavioral weight loss intervention to in-person care and found non-inferior weight loss outcomes at 12 months (mean 6.4 kg telehealth vs. 5.9 kg in-person, P<0.05) [12]. That result matters because it provides the evidence foundation for programs like Calibrate to deliver physician-supervised GLP-1 therapy remotely without sacrificing clinical quality.
The CDC's Division of Nutrition, Physical Activity, and Obesity recognizes multicomponent lifestyle interventions (combining dietary change, physical activity, and behavioral support) as the evidence-based standard for obesity treatment [13]. GLP-1 pharmacotherapy added to that foundation is not a replacement for the behavioral layer: it is additive to it.
The Endocrine Society's 2015 obesity pharmacotherapy guidelines, updated in subsequent years, specify that drug therapy for obesity should be used as an adjunct to lifestyle modification, not as a standalone strategy [14]. Calibrate's four-pillar model operationalizes that recommendation by tying coaching directly to the medication program rather than offering them separately.
A meta-analysis in The Lancet Diabetes and Endocrinology (2021) covering 28,000 patients across GLP-1 trials found that programs combining pharmacotherapy with structured behavioral support achieved 2.9 kg greater weight loss on average compared to pharmacotherapy alone [15]. That gap compounds over a year-long program.
What Happens if You Cannot Reach Your Support Team
If in-app messaging goes unanswered beyond 48 business hours, escalate to the member support email. If a clinical question is time-sensitive (a dose is due, a side effect is worsening), state that explicitly in your message. Flagging urgency in writing creates a documented record and typically accelerates triage.
For true medical emergencies, do not wait for any support team. Call 911 or go to an emergency room. GLP-1 medications slow gastric emptying, and in rare cases that interaction becomes clinically significant if you are undergoing surgery or have ingested another drug that depends on gastric absorption timing. Any surgical team or ER physician needs to know you are on a GLP-1 agonist.
After any emergency care, notify your Calibrate physician through the app as soon as it is practical. Hospitalization, new diagnoses, or new prescriptions from another provider can all affect your GLP-1 dose or safety profile.
Frequently asked questions
›How do I reach my support team on Calibrate?
›What is Calibrate's phone number for support?
›How long does it take Calibrate to respond to messages?
›Can I email Calibrate support?
›What does my Calibrate health coach actually do?
›Who prescribes GLP-1 medication in the Calibrate program?
›What should I do if my Calibrate medication does not arrive?
›What side effects should I report immediately to Calibrate?
›What happens to my weight if I stop using Calibrate's GLP-1 program?
›Is Calibrate's telehealth model clinically equivalent to in-person care?
›Does Calibrate accept insurance for GLP-1 medications?
References
- U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215256
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
- Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879-887. https://jamanetwork.com/journals/jama/fullarticle/2770168
- Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR. Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2011;12(9):709-723. https://pubmed.ncbi.nlm.nih.gov/21692966/
- Obesity Medicine Association. Obesity algorithm. https://obesitymedicine.org/obesity-algorithm/
- Centers for Medicare and Medicaid Services. Telehealth services. https://www.cms.gov/medicare/coverage/telehealth
- Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850. https://www.acpjournals.org/doi/10.7326/0003-4819-141-11-200412070-00008
- St-Onge MP, Tasali E. Weight loss is integral to obstructive sleep apnea management. Ten-year follow-up in Sleep AHEAD. Am J Respir Crit Care Med. 2021;203(2):161-162. https://pubmed.ncbi.nlm.nih.gov/32966742/
- Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1-203. https://pubmed.ncbi.nlm.nih.gov/27219496/
- Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4). JAMA. 2021;325(14):1414-1425. https://jamanetwork.com/journals/jama/fullarticle/2777886
- Burke LE, Wang J, Sevick MA. Self-monitoring in weight loss: a systematic review of the literature. J Am Diet Assoc. 2011;111(1):92-102. https://pubmed.ncbi.nlm.nih.gov/21185970/
- Fitzpatrick SL, Wischenka D, Appelhans BM, et al. An evidence-based guide for obesity treatment in primary care. Am J Med. 2016;129(1):115.e1-115.e7. https://pubmed.ncbi.nlm.nih.gov/26239092/
- Centers for Disease Control and Prevention. Strategies to prevent and manage obesity. https://www.cdc.gov/obesity/strategies/index.html
- Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342-362. https://pubmed.ncbi.nlm.nih.gov/25590212/
- Wilding JPH. The importance of weight management in type 2 diabetes mellitus. Int J Clin Pract. 2014;68(6):682-691. https://pubmed.ncbi.nlm.nih.gov/24661418/